Serine News and Research

RSS
Scientists explore immunopathology of COVID-19

Scientists explore immunopathology of COVID-19

6 May 2022
Elevated levels of PHGDH enzyme associated with Alzheimer’s disease pathology

Elevated levels of PHGDH enzyme associated with Alzheimer’s disease pathology

4 May 2022
SARS-CoV-2 BA.2 poses greater risk to global health than BA.1

SARS-CoV-2 BA.2 poses greater risk to global health than BA.1

3 May 2022
Studying immunomodulatory effects of microbiota helps design prophylactic and therapeutic interventions against COVID-19

Studying immunomodulatory effects of microbiota helps design prophylactic and therapeutic interventions against COVID-19

3 May 2022
Infectivity of SARS-CoV-2 Omicron variant in the intestinal tract

Infectivity of SARS-CoV-2 Omicron variant in the intestinal tract

3 May 2022
P681 mutations in SARS-CoV-2 spike protein determine fusogenicity

P681 mutations in SARS-CoV-2 spike protein determine fusogenicity

2 May 2022
SARS-CoV-2 Mpro inhibitors built on rattlesnake venom scaffold

SARS-CoV-2 Mpro inhibitors built on rattlesnake venom scaffold

29 Apr 2022
Study reports an orally available SARS-CoV-2 Mpro inhibitor with potent in vivo antiviral activity

Study reports an orally available SARS-CoV-2 Mpro inhibitor with potent in vivo antiviral activity

29 Apr 2022
Understanding sex differences in the pathophysiology of SARS-CoV-2 infection

Understanding sex differences in the pathophysiology of SARS-CoV-2 infection

29 Apr 2022
Study investigates intestinal ischemia in COVID-19 patients

Study investigates intestinal ischemia in COVID-19 patients

28 Apr 2022
Findings of the HITCH randomized clinical trial show lack of improvement in COVID-19 on temporary androgen suppression

Findings of the HITCH randomized clinical trial show lack of improvement in COVID-19 on temporary androgen suppression

27 Apr 2022
Nanobody effectively neutralizes pseudotyped ancestral SARS-CoV-2 and Omicron spike proteins

Nanobody effectively neutralizes pseudotyped ancestral SARS-CoV-2 and Omicron spike proteins

26 Apr 2022
ST6Gal-I–mediated sialylation of the EGFR modulates cell mechanics and enhances cancer invasion

ST6Gal-I–mediated sialylation of the EGFR modulates cell mechanics and enhances cancer invasion

22 Apr 2022
Study suggests SARS-CoV-2 is undergoing evolutionary changes at the functional RNA level in addition to the amino acid level

Study suggests SARS-CoV-2 is undergoing evolutionary changes at the functional RNA level in addition to the amino acid level

22 Apr 2022
Investigating the impact of SARS-CoV-2 Omicron spike mutations

Investigating the impact of SARS-CoV-2 Omicron spike mutations

20 Apr 2022
Study explores SARS-CoV-2 Omicron variant and infected colon epithelial cells

Study explores SARS-CoV-2 Omicron variant and infected colon epithelial cells

20 Apr 2022
Study demonstrates subset of vaccine-induced HLA-A*24:02-restricted T cells exhibits enhanced reactivity against the Omicron BA.1 variant

Study demonstrates subset of vaccine-induced HLA-A*24:02-restricted T cells exhibits enhanced reactivity against the Omicron BA.1 variant

20 Apr 2022
The involvement of the skeletal muscles in long COVID-19

The involvement of the skeletal muscles in long COVID-19

18 Apr 2022
Mutation-acquiring potential of coronaviruses and efficacies of current COVID-19 vaccines against parent and mutant strains of SARS-CoV-2

Mutation-acquiring potential of coronaviruses and efficacies of current COVID-19 vaccines against parent and mutant strains of SARS-CoV-2

18 Apr 2022
Avasimibe inhibits SARS-CoV-2 and boosts T-cell responses

Avasimibe inhibits SARS-CoV-2 and boosts T-cell responses

18 Apr 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback